During the past decade, Kara Kliewer conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kara Kliewer" #1 collaborator was "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kara Kliewer" are "Eosinophilic Esophagitis" (2 trials), "Connective Tissue Disorders" (1 trials), "Eosinophilic Disorder" (1 trials) and "Eosinophilic Gastrointestinal Disorders (EGID)" (1 trials). Many other conditions were trialed in "Kara Kliewer" in a lesser frequency.

Most popular intervention types in "Kara Kliewer" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Losartan Potassium" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kara Kliewer" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kara Kliewer". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Kara Kliewer, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kara Kliewer, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".